Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Remicade (infliximab) and Humira (adalimumab) are both biologic disease-modifying antirheumatic drug (DMARDs) used to treat various autoimmune conditions, but they have some key differences. Remicade is given through an IV infusion by a healthcare provider, while Humira is a subcutaneous injection that you can administer yourself at home. Remicade is typically given every 6 to 8 weeks, whereas Humira is usually injected every other week. Both medications are available as a brand name, but have several biosimilars available that may make it more affordable. Remicade and Humira can raise the risk of serious infections and certain cancers, but Remicade has a higher risk of causing infusion-related reactions since it is administered intravenously. Additionally, Remicade is not recommended for people with moderate or severe heart failure, while Humira can be used with caution in those with heart conditions.
Remicade (infliximab)
Humira (adalimumab)
Remicade (infliximab)
Humira (adalimumab)
Summary of Remicade vs. Humira
Summary for Biologic DMARD
Prescription only
Remicade (infliximab) is an injectable medication used to treat many autoimmune conditions, including ulcerative colitis and Crohn's disease. It's given through an intravenous (IV) infusion by a healthcare provider.
Summary for Biologic DMARD
Prescription only
Humira (adalimumab) is an injectable medication used for treating many different autoimmune conditions, including rheumatoid arthritis (RA), Crohn's disease (CD), ulcerative colitis (UC), and plaque psoriasis. It's usually given every other week, and it can be used alone or taken with methotrexate or other non-biologic medications. This medication is available as many different brands (or biosimilars).
Indications of Remicade vs. Humira
Indications for
•Moderate-to-severe Crohn's disease (CD)
•Moderate-to-severe ulcerative colitis (UC)
•Moderate-to-severe rheumatoid arthritis (RA)
•Ankylosing spondylitis (AS)
•Psoriatic arthritis (PsA)
•Severe plaque psoriasis (PsO)
Indications for
•Rheumatoid arthritis (RA) - adults only
•Juvenile idiopathic arthritis (JIA) - people age 2 and older